In this episode of Biotalk, Josh Hamermesh, VP of Locust Walk, spoke to Fred Chereau, CEO of LogicBio, an innovative early-stage gene therapy company that recently completed a $50M financing. During the conversation, Josh and Fred discussed career paths, industry trends, gene therapy and the keys to LogicBio’s successful financing.
To hear the full conversation, listen below:
<iframe width="500" height="500" scrolling="no" frameborder="no" src="https://w.soundcloud.com/player/?url=https%3A//api.soundcloud.com/tracks/347140043&color=%23ff5500&auto_play=false&hide_related=false&show_comments=true&show_user=true&show_reposts=false&show_teaser=true&visual=true"></iframe>
Subscribe here:
Click on the icons below to share on:
<script src="//platform.linkedin.com/in.js" type="text/javascript"> lang: en_US</script> <script type="IN/Share" data-url=https://www.locustwalk.com/biotalk-episode-5-fred-chereau-logicbio/"></script>